Pathak Nabin, Dhungana Shreya, Basyal Bijaya, Jha Prabhat Kumar, Shrestha Sunil, Thapa Panna, Paudyal Vibhu
Drug Information Unit and Pharmacovigilance Cell, Department of Pharmacy, Hetauda Hospital, Madan Bhandari Academy of Health Sciences, Hetauda, Bagmati Province, Nepal.
Department of Pharmacy and Clinical Pharmacology, Madan Bhandari Academy of Health Sciences, Hetauda, Bagmati Province, Nepal.
Subst Abuse Rehabil. 2024 Sep 7;15:163-171. doi: 10.2147/SAR.S466728. eCollection 2024.
The unique historical and cultural background of Nepal has shaped its perspective on cannabis usage. Narcotic Drugs Control Act 1976 of Nepal prohibits the cultivation, production, manufacture, sales, and distribution of narcotic drugs, which also include various forms of cannabis. With proponents for cannabis legalization increasing in the country, it is equally crucial to analyze context and practices in countries already adopting legalization. As such, this article contextualizes the current debates in Nepal with global policies and practices and talks about the possible impacts of changing the laws on society, the economy, and public health. Policymakers in Nepal must make decisions based on evidence and facts when deciding how to regulate cannabis.
尼泊尔独特的历史文化背景塑造了其对大麻使用的看法。尼泊尔1976年的《麻醉药品控制法》禁止麻醉药品的种植、生产、制造、销售和分销，其中也包括各种形式的大麻。随着该国支持大麻合法化的人越来越多，分析已经实行合法化的国家的情况和做法同样至关重要。因此，本文将尼泊尔当前的辩论与全球政策和做法相结合，并探讨法律变化对社会、经济和公共卫生可能产生的影响。尼泊尔的政策制定者在决定如何监管大麻时必须基于证据和事实做出决策。
